Allogene Therapeutics Growth Metrics (2018-2026) | ALLO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)			-20.51M	4.17M	-14.71M	-37.08M	-12.51M	-24.64M	1.93M	-3.45M	1.44M
EBITDA Margin Growth (3y) (Quarter)											-31.58M									36.51M
EBITDA Margin Growth (5y) (Quarter)																				16.04M
EBITDA Margin (QoQ) (Quarter)	0.29M	15.85M	-20.52M	8.55M	-18.59M	-6.52M	4.04M	-3.58M	7.97M	-11.89M	8.94M
EBIT Margin Growth (1y) (Quarter)			-20.51M	4.17M	-14.71M	-37.08M	-12.51M	-24.64M	1.93M	-3.45M	1.44M
EBIT Margin Growth (3y) (Quarter)											-31.58M									36.51M
EBIT Margin Growth (5y) (Quarter)																				16.04M
EBIT Margin (QoQ) (Quarter)	0.29M	15.85M	-20.52M	8.55M	-18.59M	-6.52M	4.04M	-3.58M	7.97M	-11.89M	8.94M
EBT Margin Growth (1y) (Quarter)			-20.89M	16.35M	-50.57M	-38.67M	-12.44M	-34.32M	41.70M	3.98M	-1.97M
EBT Margin Growth (3y) (Quarter)											-35.30M									95.70M
EBT Margin Growth (5y) (Quarter)																				34.95M
EBT Margin (QoQ) (Quarter)	0.66M	32.73M	-20.90M	3.85M	-66.26M	44.64M	5.32M	-18.02M	9.76M	6.92M	-0.62M
Enterprise Value Growth (1y) (Quarter)	49.08%	51.70%	29.76%	16.54%	-28.95%	-16.84%	-4.94%	-0.30%	15.70%	4.94%	19.61%	11.48%	38.93%	34.14%	26.08%	37.29%	11.29%	14.45%	6.57%	-21.78%
Enterprise Value Growth (3y) (Quarter)	-20.59%	4.52%	24.76%	-4.09%	-6.85%	0.78%	0.56%	18.23%	17.89%	18.75%	16.01%	9.51%	12.77%	9.90%	14.56%	17.73%	22.99%	18.79%	17.81%	12.23%
Enterprise Value Growth (5y) (Quarter)									-13.77%	0.68%	18.51%	-0.03%	8.88%	9.37%	10.19%	21.21%	21.41%	21.28%	16.36%	10.76%
Enterprise Value (QoQ) (Quarter)	27.13%	6.63%	-12.30%	-9.23%	-12.59%	15.40%	-0.87%	-4.40%	5.38%	4.60%	14.69%	-14.96%	34.72%	-2.88%	4.25%	2.47%	7.66%	0.79%	-4.56%	-24.62%
FCF Margin Growth (1y) (Quarter)			-17.97M	2.78M	-7.97M	-24.64M	-4.57M	-20.89M	-8.02M	-0.99M	-2.19M
FCF Margin Growth (3y) (Quarter)											-24.74M									28.18M
FCF Margin Growth (5y) (Quarter)																				11.35M
FCF Margin (QoQ) (Quarter)	-0.27M	9.82M	-17.98M	11.20M	-11.01M	-6.84M	2.09M	-5.11M	1.85M	0.19M	0.88M
Interest Coverage Ratio Growth (1y) (Quarter)	-207.03%	98.39%	-20.50%	-151.57%	38.43%	-860.00%	17.44%	4.82%	-215.18%	201.54%	84.54%	74.40%	-190.79%	-5,364.71%	9.32%	-289.31%	64.97%	99.53%	90.31%	6.41%
Interest Coverage Ratio Growth (3y) (Quarter)	47.68%	-22.67%	-373.29%	25.28%	42.95%	61.30%	-253.43%	-117.87%	-81.29%	29.20%	46.42%	15.05%	-78.03%	-700.61%	51.27%	1.74%	-47.52%	37.00%	76.14%	7.64%
Interest Coverage Ratio Growth (5y) (Quarter)									22.59%	82.04%	-68.37%	36.69%	-11.22%	-25.39%	-43.99%	-59.46%	-43.42%	47.85%	57.71%	10.85%
Interest Coverage Ratio (QoQ) (Quarter)	-0.69%	-55.73%	-2,649.16%	94.16%	75.36%	-2,328.29%	-136.44%	93.27%	18.40%	882.26%	-136.00%	88.86%	-826.70%	-14,062.94%	99.38%	52.16%	16.62%	-89.15%	87.15%	-5.17%
Net Margin Growth (1y) (Quarter)			-20.89M	16.35M	-50.57M	-38.67M	-12.44M	-34.32M	41.70M	3.98M	-1.97M
Net Margin Growth (3y) (Quarter)											-35.30M									95.70M
Net Margin Growth (5y) (Quarter)																				34.95M
Net Margin (QoQ) (Quarter)	0.66M	32.73M	-20.90M	3.85M	-66.26M	44.64M	5.32M	-18.02M	9.76M	6.92M	-0.62M
Operating Margin Growth (1y) (Quarter)			-20.51M	4.17M	-14.71M	-37.08M	-12.51M	-24.64M	1.93M	-3.45M	1.44M
Operating Margin Growth (3y) (Quarter)											-31.58M									36.51M
Operating Margin Growth (5y) (Quarter)																				16.04M
Operating Margin (QoQ) (Quarter)	0.29M	15.85M	-20.52M	8.55M	-18.59M	-6.52M	4.04M	-3.58M	7.97M	-11.89M	8.94M
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)		0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)										0.00M	0.00M	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	-1.00
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	-265.00	512.00	-286.00	-338.00	-313.00	-0.00M	-0.00M	-0.00M	-0.00M	-941.00	-226.00	82.00	-283.00	-9.00	-288.00	-567.00	-284.00	-173.00	358.00	0.00M
Return on Capital Employed Growth (3y) (Quarter)		0.00M	766.00	-565.00	-206.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-156.00	985.00
Return on Capital Employed Growth (5y) (Quarter)										-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Capital Employed (QoQ) (Quarter)	-211.00	623.00	-550.00	-199.00	-187.00	-0.00M	-710.00	-190.00	267.00	-309.00	5.00	119.00	-98.00	-35.00	-274.00	-161.00	185.00	77.00	257.00	951.00
Return on Sales Growth (1y) (Quarter)			-0.00M	0.00M	-0.01M	-0.00M	-0.00M	-0.00M	0.00M	398.00	-197.00	-0.00M	-0.01M	-0.01M
Return on Sales Growth (3y) (Quarter)											-0.00M	-0.00M	-0.01M	-0.02M						0.01M
Return on Sales Growth (5y) (Quarter)																				0.00M
Return on Sales (QoQ) (Quarter)	66.00	0.00M	-0.00M	385.00	-0.01M	0.00M	532.00	-0.00M	976.00	692.00	-62.00	-0.00M	-0.00M	-0.01M

Research Tools

Datasets

Plans

Developers

Allogene Therapeutics Growth Metrics (2018-2026) | ALLO

Research Tools

Datasets

Plans

Developers

Allogene Therapeutics Growth Metrics (2018-2026) | ALLO

Create an account

Sign In

Reset Password